Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. Operating Income 2022–2025
Stoke Therapeutics Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Stoke Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -53.4 M, a 148.02% decrease year-over-year.
- Stoke Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -12.6 M, a 89.07% decrease year-over-year.
- Stoke Therapeutics Inc. annual operating income for 2025 was -20.6 M, a 79.69% decrease from 2024.
- Stoke Therapeutics Inc. annual operating income for 2024 was -101.4 M, a 11.68% decrease from 2023.
- Stoke Therapeutics Inc. annual operating income for 2023 was -114.8 M, a 9.98% increase from 2022.
- Stoke Therapeutics Inc. annual operating income for 2022 was -104.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Stoke Therapeutics Inc. Operating Income — FAQ
Stoke Therapeutics Inc. (STOK) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Stoke Therapeutics Inc.'s operating income?
Stoke Therapeutics Inc. (STOK) reported operating income of -$21M for fiscal 2025.
Where can I see STOK's operating income history?
The chart and table above show Stoke Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.